Enable Injections LLC develops wearable bolus injectors for investigational use in the pharmaceutical and biotechnology industries to deliver high viscosity, high volume payloads up to 20cc to the subcutaneous tissue. The company was founded by Michael D. Hooven in February 2010 and is headquartered in Cincinnati, OH.
Cintrifuse Fund Management manages the Cintrifuse Early Stage Capital Fund I, a venture capital fund-of-funds. The fund invests in regional and national early-stage venture capital funds. The fund target venture firms with focus areas that align with its strategic funding partners interests in life sciences, consumer goods and services, technology and energy.
CincyTech focuses on investments in high-growth start-up companies located in Southwest Ohio. The firm invests primarily in the information technology, life sciences/biotechnology and advanced manufacturing and materials sectors. They provide start-up companies with management assistance, seed capital investments and connections to regional financial partners.